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Infuence of Antibody Avidity on Glomerular
Immune Complex Localization
SAMY S. ISKANDAR, MB, BCh, PhD, and
J. CHARLES JENNETrE, MD
Immune-complex-mediated glomerulonephritis (IC-
GN) was induced with daily intraperitoneal injections
of horse apoferritin (HAF) for varying intervals in
Swiss albino and BALB/c mice. Anti-HAF antibody
avidity in plasma pools from mice with predominantly
mesangial immune deposits was compared with avidity
in plasma pools from mice with predominantly capil-
lary wall deposits. Plasma from Swiss mice having pre-
dominantly mesangial deposits after 7 or 14 days of
HAF had higher avidities than plasma from Swiss mice
with predominantly capillary wall deposits after 14
EVER SINCE Germuthl and Dixon2 substantiated
the role of immune complex (IC) deposition in the
pathogenesis of serum sickness type glomerulone-
phritis (GN), investigators have been striving to elu-
cidate quantitative and qualitative aspects of immune
responses that determine the occurrence and nature
of IC-mediated glomerular lesions. The avidity of
antibodies contributing to circulating ICs has re-
cently received much attention.3-8 The reports cited
deal with two different issues. The first is the influ-
ence of antibody avidity on an individual's suscepti-
bility to GN.3 The second issue is the role played by
antibody avidity in determining the site within the
glomerulus of nephritogenic IC deposition.48 In this
communication we present observations derived
from experiments on two murine models of heterolo-
gous protein-induced IC-GN. These investigations
indicate that animals with mesangial deposition of
immune reactants have circulating antibodies of
higher avidity (relative affinity) than their counter-
parts with predominantly capillary wall deposits.
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days or more than 28 days of HAF. Plasma from
BALB/c mice with exclusively mesangial deposits after
7 days of HAF had higher avidity than plasma from
BALB/c mice with predominantly capillary wall de-
posits after 14 or more days of HAF. Therefore, there
was a correlation between glomerular site of immune
deposition and avidity of circulating anti-HAF anti-
bodies, with higher avidity antibodies associated with
mesangial immune deposits and lower avidity anti-
bodies with capillary wall deposits. (Am J Pathol 1983,
112:155-159)
mg horse apoferritin (HAF) (Calbiochem-Behring
Corporation, La Jolla, Calif) in saline for varying
periods of time. At the time of sacrifice (1 day after
the last HAF injection), heparinized blood from the
retroorbital venous plexus and kidney tissue were col-
lected. Plasma was stored at -70 C until used for as-
say, and kidney tissue was processed for light, immu-
nofluorescence, and electron-microscopic studies as
described previously.9 For immunofluorescence mi-
croscopic examination, antiserums against mouse
IgG, IgM, IgA, C3, and albumin and against horse
ferritin were used. Pools of plasma were made from
groups of mice selected on the basis of glomerular
immune deposit localization as determined by im-
munofluorescence microscopy.
The affinity of antibodies determines the rate of
dissociation of antigen-antbody complexes. When
antibodies of high affinity are equilibrated with an ex-
cess of antigen, the amount of antigen excess does
not substantially affect the chances of any particular
antibody molecule being precipitated in complex
Materials and Methods
Two-month-old male Swiss albino and BALB/c
mice (GIBCO Animal Resources Labs, Grand Island,
NY) were given daily intraperitoneal injections of 4
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form by an agent such as polyethylene glycol, be-
cause once the antigen-antibody association takes
place, dissociation is very slow to occur. On the other
hand, in the case of low-affinity antibodies, because
the rate of complex dissociation is high, increasing
the concentration of antigen in the reaction medium
enhances the chances of any antibody molecule col-
liding with an antigen molecule at any particular
moment, thus increasing the chances of that molecule
being precipitated in complex form. Therefore, the
extent of change in the amount of antigen precipi-
tated as a function of change in antigen concentra-
tion is greater for lower avidity antibodies than for
higher avidity antibodies. Hence, comparison of the
behaviors of different immune plasmas when in-
cubated with varying concentrations of the appropri-
ate antigen allows evaluation of their respective
avidities. The Scatchard equation is one of a number
of equations derived from the law of mass action"0
that can be used for that purpose."1 Affinity, strictly
speaking, refers to the strength of the bonds between
a single antibody binding site and the corresponding
antigenic determinant. Avidity, on the other hand,
applies to the strength of interaction between multi-
valent antibodies and antigens. In the literature,
however, the term "relative affinity" has frequently
been used to describe measurements carried out on
whole serum. To assay avidity (relative affinity) of
anti-HAF antibodies in our system, serial dilutions of
125I-HAF in 1:100 normal mouse plasma and phos-
phate-buffered saline (PBS) were prepared. Different
HAF concentrations were used with Swiss and
BALB/c plasmas so that the most discriminating
Scatchard plots would be generated. Triplicate 40-,ul
aliquots of each serial dilution were placed in tubes
to which 40 Ml of a fixed dilution of the plasma pool
to be assayed were added. This fixed dilution of
plasma was selected so that pools whose avidities
were to be compared bound approximately the same
amount of 125I-HAF in a quantitative anti-HAF anti-
body radioimmunoassay. The input radioactivity was
counted, and the tubes were incubated for 16 hours
on a rocking platform. Then 80 MI of 8% polyethy-
lene glycol (PEG) in PBS was added to each tube.
The tubes were shaken to ensure thorough mixing
and stored at 4 C for 1 hour. After a single dilution
with 2 ml of 4% PEG and centrifugation for 1 hour
at 1500g and 4 C, the supernatants were aspirated,
and the precipitated radioactivity was counted.
Bound and free 125I-HAF was calculated with the use
Figure 1- Direct immunofluorescence photomicrograph of a glomerulus from a Swiss mouse that received HAF for 14 days and had a predom-
inantly mesangial pattern of immune deposition. (Anti-mouse IgG, x 600) Figure 2-Direct immunofluorescence photomicrograph of a
glomerulus from a Swiss mouse that received HAF for 14 days and had predominantly capillary wall immune deposits. (Anti-mouse IgG, x 600)
(With a photographic reduction of 4%)
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Table 1 -Immunofluorescence Microscopic Findings
Immunofluorescence microscopy
Plasma pool IgG IgM C3 HAF Avidity
Swiss mice
7-day* mesangialt 2.8/0.1t 2.3/0 2.3/0 1.5/0 7.7 x 107 L/M
14-day mesangial 3.0/0.6 1.3/0 2.5/0.6 2.5/0.6 8.7 x 107 L/M
14-day capillary 0.3/3.7 1.3/0 0.5/3.3 1.7/2.3 5.6 x 107 UM
>28-day capillary 0/3.5 0.7/0 1.5/1.7 2/3.5 2.4 x 107 UM
BALB/c mice
7-day mesangial 1.8/0 2.2/0 1/0 0.5/0 2.4 x 108 UM
>14-day capillary 0.9/2.6 1.9/1.1 0.6/2.1 0.9/2.9 0.6 x 108 L/M
* Days of HAF administration.
t Predominant site of glomerular immune deposition.
t Averge mesangial/capillary intensity on a scale of 0- 4.
of Farr's correction12 and Scatchard plots constructed
by plotting bound 1251-HAF/free 125I-HAF against
bound 125I-HAF. The absolute value of the slope of
the line obtained gave the relative association con-
stant (k). This assay system allowed comparison of
avidities among different pools within each strain;
but because HAF concentrations in assays of Swiss
plasmas were different from those used to assay
BALB/c plasmas, no comparison of relative affinities
between the two strains was appropriate.
Avidity assays were performed on four Swiss
plasma pools and two BALB/c plasma pools. The
association constants determined for each of the four
Swiss plasma pools were the mean of three assays.
Swiss mouse plasma pools were from 4 mice receiving
HAF for 7 days and having almost exclusively
mesangial deposits, 4 mice receiving HAF for 14 days
and having predominantly mesangial deposits, 3 mice
receiving HAF for 14 days and having predominantly
capillary loop deposits, and 2 mice receiving HAF for
28 or more days and having predominantly capillary
loop deposits. BALB/c mouse plasma pools were
from 5 mice receiving HAF for 7 days and having
exclusively mesangial deposits and 7 mice receiving
HAF for 14 or more days and having predominantly
capillary loop deposits.
Results
Swiss Mice (Table 1)
Swiss mice with predominantly mesangial localiza-
tion of immune deposits (Figure 1) had circulating
anti-HAF of higher avidity than Swiss mice with pre-
dominantly capillary loop deposits (Figure 2). Swiss
mice with predominantly mesangial deposits had
almost the same anti-HAF avidity whether given
HAF injections for 7 days (7.7 ± 0.7 x 107 L/M) or
14 days (8.7 ± 0.6 x 10' L/M). But Swiss mice given
injections for 14 days and displaying predominantly
capillary loop immune deposits had anti-HAF avidity
of only 5.6 ± 0.3 x 107 L/M. An even lower anti-
HAF avidity of 2.4 ± 0.5 x 107 L/M was found in
Swiss mice with predominantly capillary wall depos-
its after 28 or more days of HAF. By light micros-
copy, 12 of the 13 Swiss mice used to form plasma
pools had a proliferative GN (Figure 3). One Swiss
mouse with mesangial immune deposits had no lesion
by light microscopy. No consistent correlation could
be discerned between the light-microscopic glomeru-
lar morphologic features and the site of immune
deposits or anti-HAF avidity, but by electron mi-
croscopy the distribution of immune deposits noted
by immunofluorescence microscopy corresponded to
Figure 3- Photomicrograph of a glomerulus from a Swiss mouse that
received HAF for 14 days and had a proliferative glomerulonephritis.
(H&E, x600) (With a photographic reduction of 12%)
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Figure 4- Electronmicrograph showing mesangial electron-dense deposits (arrows) in the glomerulus of a Swiss mouse that received HAF
for 14 days and had predominantly mesangial immune deposits as seen by immunofluorescence microscopy. (x 10,000) Figure 5-Electron-
micrograph showing subepithelial electron-dense deposits (arrows) in the glomerulus of a Swiss mouse that received HAF for 14 days and
had predominantly capillary wall immune deposits as seen by immunofluorescence microscopy. (x 15,000) (With a photographic reduction of 9%)
electron-dense mesangial or subepithelial deposits
(Figure 4 and 5).
BALB/c Mice (Table 1)
BALB/c mice given HAF for 7 days and having
exclusively mesangial immune deposits had an anti-
HAF avidity of 2.4 x 108 L/M, whereas BALB/c
mice injected with HAF for 14 or more days and hav-
ing predominantly capillary loop immune deposits
had a much lower anti-HAF avidity of 0.6 x 108
L/M. By electron microscopy the former group had
only mesangial electron-dense deposits, while the
latter had mesangial, subendothelial, and subepi-
thelial electron-dense deposits. Even though substan-
tial mesangial immune deposition had occurred in the
BALB/c mice given HAF for 7 days, no definite
light-microscopic lesions were identified. All 7
BALB/c mice that received HAF for 14 or more days
had marked proliferative glomerulonephritis, includ-
ing one with numerous globally necrotic glomeruli.
Discussion
The role of antibody avidity as a determinant of
site of glomerular IC localization has been repeatedly
investigated in recent years. The earliest study ad-
dressing this point was that published by Kuriyama in
1973.4 In this study, in 4 rabbits chronically immu-
nized with egg albumin a lesion developed that was
somewhat similar to human membranous glomeru-
lopathy except for the presence of mesangial and
subendothelial dense deposits in addition to subepi-
thelial deposits classically seen in this entity. These
animals were shown, using Farr's method, to produce
antibodies of relatively lower avidity, compared with
2 other animals in which mesangioproliferative GN
developed with electron-dense deposits essentially
confined to the mesangium.
In 1978 Koyama et als formed ICs in vitro with
antibodies of different affinities, as determined by
equilibrium dialysis. These complexes were injected
intravenously into C57BL mice. Mice given "high
affinity" complexes showed glomerular hypercellu-
larity associated with mesangial deposits visualized
both by immunofluorescence and electron microsco-
py. On the other hand, mice given "moderate affin-
ity" complexes displayed the presence of immune
reactants both in the mesangium and in the subendo-
thelial area but not in the subepithelial compartment.
More recently, Germuth et al6l7 used a mouse
model of passive IC-GN and showed that egg al-
bumin-anti-egg albumin complexes induced a mes-
angiopathy if they were formed with highly avid
antibodies, whereas a proliferative GN with subepi-
thelial deposits resulted when the complexes were
AJP * August 1983
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formed with poorly avid antibodies. In his studies
Germuth defined the avidity of antibodies by the
extent of solubility of ICs formed at equivalence in
a pH 4 citrate buffer. Devey and Steward,8 working
with mouse lines producing high and low avidity anti-
bodies, respectively, found that during IC-GN the
high avidity line displayed predominantly mesangial
immune deposits and the low avidity line had pre-
dominantly capillary wall deposits.
Our results are thus in accord with previous re-
ports. The comparison of antibody avidities over
time in the two models suggests that continued anti-
genic stimulation reduces the avidity of the anti-
bodies produced. This could be explained by the
progressive recruitment of populations of antibody-
producing cells which synthesize antibodies with less
and less adequate fits for the determinants on the
HAF molecule.
One interpretation of the relationship between
antibody avidity and site of glomerular IC localiza-
tion is that relatively avid antibodies form large ICs,
which localize in the mesangium. Antibodies of low
avidity, on the other hand, form smaller complexes,
which successfully achieve a capillary wall localiza-
tion. This straightforward explanation should, how-
ever, be taken with reservation, because there is no
guarantee that the ICs remaining in the circulation
are representative of ICs deposited in the glomeruli.
Indeed, evidence has been brought forth in two pub-
lications13 14 that this might not be the case. Steward13
found that after GN induction the renal eluate from
both high and low avidity antibody producing lines
contained what he considered to be high avidity anti-
bodies. Similarly, Winfield et al14 reported that anti-
native-DNA antibody avidity was significantly lower
in lupus patients with active nephritis as compared
with those without nephritis. However, anti-native-
DNA eluted from glomeruli of nephritic patients was
highly avid in all cases studied. These reports raise
the possibility that only selected populations of cir-
culating ICs lodge in the glomeruli.
Another possible explanation of the observations
under consideration would be that under conditions
of high antibody avidity ICs once formed rarely dis-
sociated and deposited from the circulation into the
mesangium, while under conditions of low avidity
ICs had a high rate of dissociation predisposing to
independent penetration of antibody and antigen
into capillary walls and resultant in situ formation.
In summary, the data presented substantiate a cor-
relation between the glomerular site of IC deposition
and the average avidity of circulating antibodies
available to participate in the formation of these ICs.
Higher avidity antibodies were associated with
mesangial immune deposits and lower avidity anti-
bodies with capillary wall immune deposits.
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